17.75USD+4.29%Mkt Cap: 1.97B $P/E: —1d ago
Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provid…
Industry Peers
Drug Manufacturers - Specialty & Generic$64.41BUSDP/E 23.3
$22.74BUSDP/E 19.8
$20.14BUSD
$17.18BUSDP/E 26.3
$15.40BUSDP/E 118.1
$14.51BUSDP/E 30.3
$12.90BUSD
$9.04BUSDP/E 23.0
$7.60BUSD
$7.11BUSDP/E 470.2
$7.00BUSDP/E 25.7
$5.70BUSDP/E 48.2
$3.69BUSDP/E 19.2
$3.57BUSDP/E 11.4
$3.01BUSDP/E 21.0
$2.79BUSD
$2.53BUSDP/E 56.2
$2.33BUSDP/E 16.1
$2.36BUSDP/E 12.8
$2.36BUSD
$1.90BUSDP/E 19.2
$1.80BUSDP/E 20.3
$1.84BUSD
$1.74BUSD
$1.57BUSD
$1.48BUSDP/E 17.5
$1.52BUSDP/E 125.7
$1.35BUSDP/E 14.3
$1.21BUSDP/E 38.0
$1.17BUSDP/E 17.5
$1.16BUSD
$1.20BUSD
$1.07BUSDP/E Infinity
$1.01BUSD
$1.01BUSDP/E 197.0
$902.17MUSDP/E 14.5
$883.62MUSDP/E 38.6
$870.61MUSDP/E 11.9
$819.46MUSDP/E Infinity
$664.05MUSD
$702.13MUSDP/E 163.7
$635.41MUSDP/E 6.2
$503.88MUSDP/E 14.2
$516.92MUSD
$463.93MUSD
$437.60MUSD
$393.68MUSD
$377.35MUSD
$359.47MUSD
$339.22MUSD
$337.13MUSD
$319.75MUSDP/E 43.6
$351.79MUSD
$303.26MUSDP/E 9.7
$290.59MUSD
$267.31MUSDP/E 48.0
$280.94MUSDP/E 14.5
$250.29MUSDP/E 47.6
$246.73MUSDP/E 12.3
$233.72MUSDP/E 52.4
$207.94MUSDP/E 10.3
$202.91MUSD
$197.15MUSD
$187.92MUSDP/E 9.0
$175.54MUSD
$166.91MUSD
$143.51MUSDP/E 18.3
$132.34MUSD
$141.87MUSD
$128.15MUSD
$119.66MUSDP/E 18.6
$102.48MUSD
$85.39MUSDP/E 12.3
$93.61MUSD
$72.08MUSD
$65.22MUSD
$68.77MUSD
$63.45MUSDP/E 29.2
$60.45MUSDP/E 51.0
$64.05MUSD
$53.24MUSD
$52.01MUSD
$51.08MUSD
$49.45MUSD
$41.74MUSD
$46.21MUSD
$33.86MUSDP/E Infinity
$37.20MUSD
$31.62MUSD
$27.40MUSD
$24.18MUSD
$23.84MUSDP/E 206.0
$23.98MUSD
$23.08MUSD
$22.15MUSD
$18.78MUSD
$18.30MUSD
$14.93MUSD
$13.64MUSDP/E 16.6
$13.96MUSD
$11.82MUSD
$11.45MUSD
$9.96MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.51MUSDP/E 4.0
$6.35MUSD
$5.98MUSDP/E 0.2
$5.79MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$1.93MUSD
$1.85MUSD
$1.85MUSDP/E 31.6
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap1.97B $
Enterprise Value1.62B $
Revenue (TTM)—
Gross Profit0 $
Net Income (TTM)-144.74M $
Revenue/Share—
Last Price17.75 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees136
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-13.44
PEG—
EV/EBITDA-10.19
EV/Revenue—
P/S—
P/B6.92
EPS (TTM)-1.48
EPS (Forward)-1.27
52W Range
7.48088% of range19.15
52W High19.15 USD
52W Low7.480 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-47.41%
ROA-43.51%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-123.34M $
CapEx (TTM)138.00K $
FCF Margin—
FCF Yield-3.62%
Net Debt-274.14M $
Net Debt/EBITDA1.73
Balance Sheet
Debt/Equity0.02
Current Ratio17.85
Quick Ratio17.53
Book Value/Sh2.460 USD
Cash/Share2.516 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)24.40 USD
Upside (mean)+37.5%
Target Range19.00 USD – 40.00 USD
$19.00+37.5% to mean$40.00
# Analysts10
Ownership
Shares Out.111.19M
Float83.55M
Insiders7.89%
Institutions105.37%
Short Interest
Short Ratio7.8d
Short % Float16.74%
Short % Out.12.94%
Shares Short14.39M
Short (prev mo.)14.96M
Technical
SMA 5015.44 (+14.9%)
SMA 20014.54 (+22.0%)
Beta-0.20
S&P 52W Chg20.25%
Avg Vol (30d)1.58M
Avg Vol (10d)1.35M
Technical Indicators
RSI (14)57.1
MACD0.6766
MACD Signal0.8092
MACD Hist.-0.1326
BB Upper19.31 USD
BB Middle17.46 USD
BB Lower15.60 USD
BB Width21.23%
ATR (14)1.044 USD
Vol Ratio (20d)0.79x